Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Peripheral stem cells: from biology to therapy]

U Coppetelli, M Tribalto, G Papa

    Recenti Progressi in Medicina
    |April 1, 1995
    PubMed
    Summary

    High-dose chemotherapy can be limited by blood toxicity, but autologous stem cell transplantation (ASCT) helps mitigate this. Recombinant human growth factors are used to reduce recovery time after ASCT.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Scapular dyskinesis after breast reconstruction surgery for breast cancer: a retrospective clinical analysis on 67 patients.

    Musculoskeletal surgery·2025
    Same author

    Acute and chronic effects of Titanium dioxide (TiO<sub>2</sub>) PM<sub>1</sub> on honey bee gut microbiota under laboratory conditions.

    Scientific reports·2021
    Same author

    Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group.

    Annals of hematology·2021
    Same author

    Unmet needs and relationship between general practitioners (GPs) and allergists living in Campania region (southern Italy).

    European annals of allergy and clinical immunology·2020
    Same author

    Relationship between sugarcane culm and leaf biomass composition and saccharification efficiency.

    Biotechnology for biofuels·2019
    Same author

    Use of licap and ltap flaps for breast reconstruction.

    Acta chirurgiae plasticae·2019

    Area of Science:

    • Oncology
    • Hematology
    • Transplantation Medicine

    Background:

    • Aggressive chemotherapy regimens, including alkylating agents, antimetabolites, and anthracyclines, show efficacy against various malignancies.
    • High-dose chemotherapy is often limited by severe hematological toxicity.
    • Autologous stem cell transplantation (ASCT) is a supportive care strategy to mitigate chemotherapy-induced hematological toxicity.

    Discussion:

    • ASCT involves the transplantation of autologous stem cells, which can be sourced from bone marrow or peripheral blood.
    • Recombinant human growth factors such as G-CSF, GM-CSF, and IL3 are administered to shorten the duration of marrow aplasia post-transplant.
    • Peripheral blood stem cell autograft is increasingly favored, particularly in patients with pre-existing bone marrow hypocellularity due to irradiation or neoplastic infiltration.

    Key Insights:

    • ASCT effectively reduces the hematological toxicity associated with aggressive chemotherapy.
    • The use of recombinant human growth factors enhances stem cell recovery after transplantation.
    • Peripheral blood stem cell transplantation offers a viable alternative, especially in compromised bone marrow environments.

    Outlook:

    • Further research into optimizing growth factor administration and stem cell collection methods.
    • Exploring the long-term efficacy and safety of ASCT in diverse oncological settings.
    • Investigating novel approaches to further enhance patient tolerance to high-dose chemotherapy.

    Related Experiment Videos